Skip to Content

M P8 (Pantoprazole sodium delayed release 20 mg)

Pill imprint M P8 has been identified as Pantoprazole sodium delayed release 20 mg.

Pantoprazole is used in the treatment of barrett's esophagus; gerd; dumping syndrome; erosive esophagitis; helicobacter pylori infection (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pantoprazole sodium delayed release 20 mg M P8
Pantoprazole sodium delayed release 20 mg M P8
Discount Card Promo
Pantoprazole sodium delayed release
Imprint:
M P8
Strength:
20 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Matrix Laboratories Limited
National Drug Code (NDC):
00378-6688
Inactive Ingredients:
ammonia
ferrosoferric oxide
calcium stearate
crospovidone
hypromelloses
mannitol
methacrylic acid - ethyl acrylate copolymer (1:1) type a
povidone
propylene glycol
sodium carbonate
shellac
titanium dioxide
triethyl citrate
ferric oxide yellow

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide